Byrne Thomas E 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jan 9, 2020
Insider Transaction Report
Form 4
Byrne Thomas E
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-01-07+25,000→ 25,000 totalExercise: $0.42Exp: 2022-12-31→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 1, 2020.